A total number of 368 clinical isolates of Streptococcus agalactiae (group B Streptococcus, GBS) were collected in 2010–2016 from three hospitals in a region of central Italy. Fluoroquinolone (FQ)-resistant isolates were selected using levofloxacin. Levofloxacin-resistant (LR) strains (11/368, 2.99%) were characterized for several features, and their FQ resistance was analyzed phenotypically and genotypically using seven additional FQs. Their gyrA and parC quinolone resistance-determining regions were sequenced. Of the 11 LR isolates, 10 showed high-level and 1 low-level resistance. The former isolates exhibited higher minimal inhibitory concentrations also of the other FQs and all shared one amino acid substitution in ParC (Ser79Phe) and one in GyrA (Ser81Leu); only Ser79Phe in ParC was detected in the low-level LR isolate. The 11 LR strains exhibited distinctive relationships between their susceptibilities to non-FQ antibiotics and typing data. Remarkably, despite the very rare occurrence of chloramphenicol resistance in S. agalactiae, no <4 of the 11 LR isolates were chloramphenicol-resistant. Studies of GBS resistance to FQs in Europe remain scarce, notwithstanding the emergence of multidrug-resistant isolates. The incidence of LR GBS isolates is still limited in Italy, consistent with the moderate (though growing) rates reported in Europe, and much lower than the very high rates reported in East Asia. The intriguing relationships between FQ and chloramphenicol resistance deserve further investigation.
Get full access to this article
View all access options for this article.
References
1.
SendiP., JohanssonL., and Norrby-TeglundA., 2008. Invasive group B streptococcal disease in non-pregnant adults: a review with emphasis on skin and soft-tissue infections. Infection., 36:100–111.
2.
SkoffT.H., FarleyM.M., PetitS., CraigA.S., SchaffnerW., GershmanK., HarrisonL.H., LynfieldR., Mohle-BoetaniJ., ZanskyS., AlbaneseB.A., StefonekK., ZellE.R., JacksonD., ThompsonT., and SchragS.J., 2009. Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990–2007. Clin. Infect. Dis., 49:85–92.
3.
KimuraK., SuzukiS., WachinoJ., KurokawaH., YamaneK., ShibataN., NaganoN., KatoH., ShibayamaK., and ArakawaY., 2008. First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob. Agents Chemother., 52:2890–2897.
4.
BackE.E., O'GradyE.J., and BackJ.D., 2012. High rates of perinatal group B Streptococcus clindamycin and erythromycin resistance in an upstate New York Hospital. Antimicrob. Agents Chemother., 56:739–742.
5.
FlorindoC., DamiãoV., SilvestreI., FarinhaC., RodriguesF., NogueiraF., Martins-PereiraF., CastroR., BorregoM.J., Santos-SanchesI., and Group for the Prevention of Neonatal GBS Infection. 2014. Epidemiological surveillance of colonising group B Streptococcus epidemiology in the Lisbon and Tagus Valley regions, Portugal (2005 to 2012): emergence of a new epidemic type IV/clonal complex 17 clone. Euro. Surveil., 19:20825.
6.
BergalA., LoucifL., BenouarethD.E., BentorkiA.A., AbatC., and RolainJ.M., 2015. Molecular epidemiology and distribution of serotypes, genotypes, and antibiotic resistance genes of Streptococcus agalactiae clinical isolates from Guelma, Algeria and Marseille, France. Eur. J. Clin. Microbiol. Infect. Dis., 34:2339–2348.
7.
WangP., TongJ., MaX., SongF., FanL., GuoC., ShiW., YuS.J., YaoK.H., and YangY.H., 2015. Serotypes, antibiotic susceptibilities, and multi-locus sequence type profiles of Streptococcus agalactiae isolates circulating in Beijing, China. PLoS One., 10:e0120035.
8.
KawamuraY., FujiwaraH., MishimaN., TanakaY., TanimotoA., IkawaS., ItohY., and EzakiT., 2003. First Streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyrA and parC. Antimicrob. Agents Chemother., 47:3605–3609.
9.
BiedenbachD.J., TolemanM.A., WalshT.R., and JonesR.N., 2006. Characterization of fluoroquinolone-resistant β-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997–2004). Diagn. Microbiol. Infect. Dis., 55:119–127.
10.
WuH., JanapatlaR.P., HoY., HungK., WuC., YanJ., and WuJ.J., 2008. Emergence of fluoroquinolone resistance in group B streptococcal isolates in Taiwan. Antimicrob. Agents Chemother., 52:1888–1890.
11.
PiccinelliG., GargiuloF., CorbelliniS., RavizzolaG., BonfantiC., CarusoA., and De FrancescoM.A., 2015. Emergence of the first levofloxacin-resistant strains of Streptococcus agalactiae isolated in Italy. Antimicrob. Agents Chemother., 59:2466–2469.
12.
HaysC., LouisM., PlainvertC., DmytrukN., TouakG., and Trieu-CuotP., 2016. Changing epidemiology of group B Streptococcus susceptibility to fluoroquinolones and aminoglycosides in France. Antimicrob. Agents Chemother., 60:7424–7430.
HooperD.C.2002. Fluoroquinolone resistance among Gram-positive cocci. Lancet. Infect. Dis., 2:530–538.
15.
MaedaY., MurayamaM., GoldsmithC.E., CoulterW.A., MasonC., MillarB.C., DooleyJ.S., LoweryC.J., MatsudaM., RendallJ.C., ElbornJ.S., and MooreJ.E., 2011. Molecular characterization and phylogenetic analysis of quinolone resistance-determining regions (QRDRs) of gyrA, gyrB, parC and parE gene loci in viridans group streptococci isolated from adult patients with cystic fibrosis. J. Antimicrob. Chemother., 66:476–486.
16.
WehbehW., Rojas-DiazR., LiX., MarianoN., GrennerI., Segai-MaurerS., TommasuloB., DrlicaK., UrbanC., and RahalJ.J., 2005. Fluoroquinolone-resistant Streptococcus agalactiae: epidemiology and mechanism of resistance. Antimicrob. Agents Chemother., 49:2495–2497.
17.
European Committee on Antimicrobial Susceptibility Testing (EUCAST). 2017. Available at www.eucast.org.
18.
PanX.S., AmblerJ., MehtarS., and FisherL.M., 1996. Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrob. Agents Chemother., 40:2321–2326.
19.
MingoiaM., MoriciE., MorroniG., GiovanettiE., Del GrossoM., PantostiA., and VaraldoP.E., 2014. Tn5253 family integrative and conjugative elements carrying mef(I) and catQ determinants in Streptococcus pneumoniae and Streptococcus pyogenes. Antimicrob. Agents Chemother., 58:5886–5893.
20.
MoriciE., SimoniS., BrencianiA., GiovanettiE., VaraldoP.E., and MingoiaM., 2017. A new mosaic integrative and conjugative element from Streptococcus agalactiae carrying resistance genes for chloramphenicol (catQ) and macrolides [mef(I) and erm(TR)]. J. Antimicrob. Chemother., 72:64–67.
21.
BrencianiA., TiberiE., TiliE., MingoiaM., PalmieriC., VaraldoP.E., and GiovanettiE., 2014. Genetic determinants and elements associated with antibiotic resistance in viridans group streptococci. J. Antimicrob. Chemother., 69:1197–1204.
22.
MingoiaM., MoriciE., MariniE., BrencianiA., GiovanettiE., and VaraldoP.E., 2016. Macrolide resistance gene erm(TR) and erm(TR)-carrying genetic elements in Streptococcus agalactiae: characterization of ICESagTR7, a new composite element containing IMESp2907. J. Antimicrob. Chemother., 71:593–600.
23.
ImperiM., PataracchiaM., AlfaroneG., BaldassarriL., OreficiG., and CretiR., 2010. A multiplex PCR assay for the direct identification of the capsular type (Ia to IX) of Streptococcus agalactiae. J. Microbiol. Methods., 80:212–214.
24.
JonesN., BohnsackJ.F., TakahashiS., OliverK.A., ChanM., KunstF., GlaserP., RusniokC., CrookD.W., HardingR.M., BisharatN., and SprattB.G., 2003. Multilocus sequence typing system for group B Streptococcus. J. Clin. Microbiol., 41:2530–2536.
25.
CretiR., FabrettiF., OreficiG., and von HunolsteinC., 2004. Multiplex PCR assay for direct identification of group B streptococcal alpha-protein-like protein genes. J. Clin. Microbiol., 42:1326–1329.
26.
YanS.S., FoxM.L., HollandS.M., StockF., GillV.J., and FedorkoD.P., 2000. Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: identification of gyrA and parC and specification of point mutations associated with resistance. Antimicrob. Agents Chemother., 44:3196–3198.
27.
MontanariM.P., TiliE., CochettiI., MingoiaM., ManzinA., and VaraldoP.E., 2004. Molecular characterization of clinical Streptococcus pneumoniae isolates with reduced susceptibility to fluoroquinolones emerging in Italy. Microb. Drug Resist., 10:209–217.
28.
BiedenbachD.J., StephenJ.M., and JonesR.N., 2003. Antimicrobial susceptibility profile among β-haemolytic Streptococcus spp. collected in the SENTRY Antimicrobial Surveillance Program—North America, 2001. Diagn Microbiol Infect Dis., 46:291–294.
29.
Figueira-CoelhoJ., RamirezM., SalgadoM.J., and Melo-CristinoJ., 2004. Streptococcus agalactiae in a large Portuguese teaching hospital: antimicrobial susceptibility, serotype distribution, and clonal analysis of macrolide-resistant isolates. Microb. Drug Resist., 10:31–36.
30.
ShabayekS., and AbdallaS., 2014. Macrolide- and tetracycline-resistance determinants of colonizing group B Streptococcus in women in Egypt. J. Med. Microbiol., 63:1324–1i327.
31.
MetcalfB.J., ChochuaS., GertzR.EJr, HawkinsP.A., RicaldiJ., LiZ., WalkerH., TranT., RiversJ., MathisS., JacksonD., GlennenA., LynfieldR., McGeeL., BeallB., and Active Bacterial Core surveillance team. 2017. Short-read whole genome sequencing for determination of antimicrobial resistance mechanisms and capsular serotypes of current invasive Streptococcus agalactiae recovered in the United States. Clin. Microbiol. Infect, 2017 [Epub ahead of print]. DOI:10.1016/j.cmi.2017.02.021.
32.
RoodJ.I., JeffersonS., BannamT.L., WilkieJ.M., MullanyP., and WrenB.W., 1989. Hybridization analysis of three chloramphenicol resistance determinants from Clostridium perfringens and Clostridium difficile. Antimicrob. Agents Chemother., 3:1569–1574.
33.
MingoiaM., VecchiM., CochettiI., TiliE., VitaliL.A., ManzinA., VaraldoP.E., and MontanariM.P., 2007. Composite structure of Streptococcus pneumoniae containing the erythromycin efflux resistance gene mef(I) and the chloramphenicol resistance gene catQ. Antimicrob. Agents Chemother., 51:3983–3987.
34.
MingoiaM., MoriciE., BrencianiA., GiovanettiE., and VaraldoP.E., 2015. Genetic basis of the association of resistance genes mef(I) (macrolides) and catQ (chloramphenicol) in streptococci. Front. Microbiol., 5:747.
35.
ChaffanelF., Charron-BourgoinF., LibanteV., Leblond-BourgetN., and PayotS., 2015. Resistance genes and genetic elements associated with antibiotic resistance in clinical and commensal isolates of Streptococcus salivarius. Appl. Environ. Microbiol., 81:4155–4163.
36.
HorinouchiS., and WeisblumB., 1982. Nucleotide sequence and functional map of pC194, a plasmid that specifies inducible chloramphenicol resistance. J. Bacteriol., 150:815–825.
37.
AyoubiP., KilicA.O., and VijayakumarM.N., 1991. Tn5253, the pneumococcal Ω(cat tet) BM6001 element, is a composite structure of two conjugative transposons, Tn5251 and Tn5252. J. Bacteriol., 173:1617–1622.
38.
MurayamaS.Y., SekiC., SakataH., SunaoshiK., NakayamaE., IwataS., SunakawaK., UbukataK., and Invasive Streptococcal Disease Working Group. 2009. Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections. Antimicrob. Agents Chemother., 53:2650–2653.
39.
WangH., ZhaoC., HeW., ZhangF., ZhangL., CaoB., SunZ., XuY., YangQ., MeiY., HuB., ChuY., LiaoK., YuY., HuZ., and NiY., 2013. High prevalence of fluoroquinolone-resistant group B streptococci among clinical isolates in China and predominance of sequence type 19 with serotype III. Antimicrob. Agents Chemother., 57:1538–1541.
40.
RyuH., ParkY-J., KimY., ChangJ., and YuJ.K., 2014. Dominance of clonal complex 10 among the levofloxacin-resistant Streptococcus agalactiae isolated from bacteremic patients in a Korean hospital. J. Infect. Chemother., 20:509–511.
41.
MorozumiM., WajimaT., TakataM., IwataS., and UbukataK., 2016. Molecular characteristics of group B streptococci isolated from adults with invasive infections in Japan. J. Clin. Microbiol., 54:2695–2700.
42.
CampisiE., RosiniR., JiW., GuidottiS., Rojas-LópezM., GengG., DengQ., ZhongH., WangW., LiuH., NanC., MargaritI., and RinaudoC.D., 2016. Genomic analysis reveals multi-drug resistance clusters in group B Streptococcus CC17 hypervirulent isolates causing neonatal invasive disease in southern mainland China. Front. Microbiol., 7:1265.
